A randomised trial of therapy shortening for minimal tuberculosis with new WHO-recommended doses and FDC drugs in African/Indian HIV+/HIV- children

This website will not work correctly in Internet Explorer 11 and it is strongly recommended that you upgrade to an up-to-date browser. Internet Explorer 11 will go out of support and be retired on June 15, 2022. For more information on upgrading please see browser-update.org.